Robert Gil

2 ta ish

Central Clinical Hospital

1. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment

   Robert Gil, Jacek Bil, Tomasz Pawłowski +5

   MaqolaOAOchiq kirishCoronary Interventions and DiagnosticsKardiologia Polska20160 iqtibos

   ABIABI:AkademIndex/2016.article.000135

2. One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent

   Nabijon Yuldashev, Robert Gil, R. D. Kurbanov

   MaqolaOAOchiq kirishCoronary Interventions and DiagnosticsInternational Journal of Biomedicine20180 iqtibos

   ABIABI:AkademIndex/2018.article.000491